Friday, May 1, 2026

Alteogen Secures U.S. Patent for Keytruda Subcutaneous Injection: What This Means for ALT-B4 and Future Treatments

Alteogen secures a U.S. patent for a subcutaneous Keytruda formulation using ALT-B4, ensuring exclusivity until 2043 and potential $1B in sales.

Apple’s Stock Drops 2.07% Over Foldable Phone Delay

Apple's stock fell over 2% due to delays in launching a foldable phone, but recovery is possible with a September release alongside iPhone 18.

South Korean Trade Minister to Visit U.S. Amid Escalating Tariff Tensions

South Korea's Trade Minister visits the U.S. to discuss tariffs and strengthen bilateral cooperation under Trump's administration.

Tag: Tokyo accommodations

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.